Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

rPCI-24781 is an orally-bioavailable histone deacetylase inhibitor that is in multiple clinical trials. We are conducting a Phase I trial in patients with advanced solid tumors, a Phase I/II trial in sarcoma patients (in combination with doxorubicin, an anti tumor agent) and a Phase I/II trial  testing PCI-24781 in patients with relapsed or refractory Non-Hodgkin's lymphoma. Currently we are enrolling the final follicular lymphoma patients in the Phase II portion of this trial and expect to complete enrollment by Q4 of calendar 2011.  Our collaboration partner for ex-US development, Servier, has five Phase I and I/II trials ongoing in Europe in lymphomas and solid tumors.

Conference Call and Webcast DetailsThe Company will hold a conference call today at 4:30 p.m. EDT. To participate in the conference call, please dial 1-877-407-8133 for domestic callers and 1-201-689-8040 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. The archived version of the webcast will be available for 30 days on the Investor Relations section of the company's Web site at www.pharmacyclics.com.

For further questions please contact Ramses Erdtmann, VP Finance at: 408-215-3325

Non-Hodgkin's Lymphoma (NHL) Market There are significant and distinct areas of unmet medical need across the NHL subtypes.  Within the indolent lymphomas, we believe a need exists for active therapies that avoid the toxicities typically seen with conventional chemotherapies. Such active therapies are needed as part of effective combinations early in the course of treatment, and also as effective single-agent treatments later in the course of disease progression.  In particular, drugs which are well tolerated and which do not limit subsequent treatment options b
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014 According to a ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic Navigation ... and Forecast, 2014 - 2020", the global surgical navigation ... 2013 and is expected to grow at a CAGR ... estimated value of USD 295.5 million in 2020. ...
(Date:8/18/2014)... Gamida Cell , ... products, announced today that it has signed an investment and ... " Novartis " ) . According to ... and in return will receive 15% equity and an option ... a limited period of time following achievement of certain milestones ...
(Date:8/18/2014)... Aug. 18, 2014 Reportlinker.com announces that ... its catalogue: Russia Bariatric ... http://www.reportlinker.com/p02280986/Russia-Bariatric-Surgery-Devices-Market-Outlook-to-2020.html Russia Bariatric ... Summary GlobalData,s new report, "Russia ... key market data on the Russia Bariatric Surgery ...
Breaking Medicine Technology:Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 2Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 3Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 4Russia Bariatric Surgery Devices Market Outlook to 2020 2Russia Bariatric Surgery Devices Market Outlook to 2020 3Russia Bariatric Surgery Devices Market Outlook to 2020 4Russia Bariatric Surgery Devices Market Outlook to 2020 5
(Date:8/19/2014)... Skmen.com, an outstanding company in the garment industry, has unveiled ... addition to this, the company has also launched a big ... available at low rates, up to 30 percent off. ... beautiful bohemian outfits are available in many colours, including green, ... top quality clothes, reasonable prices and sincere service, the company ...
(Date:8/19/2014)... 2014 Recently, CanadaGooseJackor.nu, a popular supplier of ... Canada Goose Solaris Parkas . All clients that place ... discounted price (up to 35% off) before the end of ... in an online supplier’s business. CanadaGooseJackor.nu is a great platform ... all over the world can enjoy its dedicated professional service ...
(Date:8/19/2014)... LunaDress, a popular supplier of fashionable wedding, bridesmaid, ... now providing a discount of up to 67% on ... white prom outfits are available in different necklines; ladies ... , There are over 400 cheap white prom dresses ... offer is valid until August 29, 2014. The discounted ...
(Date:8/19/2014)... Recently, UWDress.com, a professional company of women’s dresses ... plus size formal evening dresses . Additionally, the firm has ... At the moment, all of them can be ordered at ... be valid until August 27, 2014. , The company ... designers believe that women of all shapes can be graceful ...
(Date:8/19/2014)... Recently, iFitDress.com,a leading online supplier of ... its new collection of pewter evening dresses . ... company’s global market. Each item is carefully made with ... spokesman, customers that have specific requirements can also order ... the brand new items are offered at discounted prices, ...
Breaking Medicine News(10 mins):Health News:2014 Bohemian Dresses Now for Sale at Skmen.com 2Health News:High Quality Canada Goose Solaris Parkas For Sale At CanadaGooseJackor.nu 2Health News:Popular Supplier LunaDress Providing an Exclusive Assortment of White Prom Dresses at a Discount of Up to 67% 2Health News:Cheap Plus Size Formal Evening Dresses Announced By UWDress.com 2Health News:Discounted Pewter Evening Dresses For 2014 Unveiled By Company iFitDress.com 2
... boost survival, German study shows , MONDAY, June ... performing radical hysterectomy in early-stage cervical cancer patients ... tumor recurrence, a German study shows. , The ... modified version of traditional radical hysterectomy. But this ...
... Plan Takes Holistic Approach in Seeking New Solutions to Improve ... Calif., June 1 More than 200 physicians and nurses ... to address a myriad of issues surrounding geriatric care in ... dementia and prostate cancer to more process-oriented issues such as ...
... 1, 2009) The latest advances in polyp detection, ... colonoscopy will be presented today at Digestive Disease Week ... size and type of polyps detected during colonoscopy and ... insight into the recommended frequency of follow-up preventive colonoscopy. ...
... heartbeat can indicate distress, but currently there is no ... when it could be too late to prevent serious ... system developed by an MIT scientist and colleagues including ... fetal heartbeat. The additional researchers are from the Institut ...
... , - John Hancock AnnuityNote Variable Annuity offers a simplified ... Market participation with downside protection , , - Simple ... John Hancock today announced the launch of a new retirement ... income to a broader market beyond the reach of traditional ...
... and the Alzheimer,s Association Support Award to Recognize Critical Role ... N.J., June 1 Eisai Inc., ... Alzheimer,s disease and their caregivers across America to nominate local ... A lzheimer,s. R ecognition of E xcellence.) Pharmacy ...
Cached Medicine News:Health News:Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 2Health News:Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 3Health News:New research identifies more effective tools for detection of colorectal cancer 2Health News:New research identifies more effective tools for detection of colorectal cancer 3Health News:New research identifies more effective tools for detection of colorectal cancer 4Health News:New research identifies more effective tools for detection of colorectal cancer 5Health News:New research identifies more effective tools for detection of colorectal cancer 6Health News:New research identifies more effective tools for detection of colorectal cancer 7Health News:MIT: New system monitors fetal heartbeat 2Health News:MIT: New system monitors fetal heartbeat 3Health News:John Hancock Launches New Retirement Income Solution 2Health News:John Hancock Launches New Retirement Income Solution 3Health News:John Hancock Launches New Retirement Income Solution 4Health News:John Hancock Launches New Retirement Income Solution 5Health News:Call for Nominations for the 2009 C.A.R.E. Pharmacy Award 2Health News:Call for Nominations for the 2009 C.A.R.E. Pharmacy Award 3
... EDTA K2 / gel tubes are ... for molecular diagnostics and for viral ... whole blood remain stable at room ... For optimal results, it is recommended ...
... offered as either EDTA K2 or ... calcium ions and therefore blocks the ... in an EDTA anticoagulated blood sample ... hours. EDTA tubes are for the ...
... is a ubiquitous enzyme that catalyzes ... is also the specific protein that ... immunofluorescence (EMA) tests (Bio-Rad catalog number ... serologic tests are highly sensitive and ...
... blood oximeters provide cardiologists with critical ... a patient's blood. The Oxicom series ... over a half-million saturation samples measured ... cost-effective oxygen saturation readings in less ...
Medicine Products: